Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy

Lucio Tentori, Maria Pia Fuggetta, Stefania D'Atri, Angelo Aquino, Corrado Nunziata, Mario Roselli, Paolo Ballatore, Enzo Bonmassar, Liana De Vecchis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The present study was designed to test whether immunomodulating doses of human beta-interferon would affect the natural cell-mediated cytotoxic function in untreated breast cancer patients or in those subjected to antitumor therapy. Analyses were performed on 11 breast cancer patients, 3 at stage 1 and 8 at stage 2, the latter being subjected to cyclophosphamide, methotrexate, 5-Fluorouracil (CMF) adjuvant chemotherapy. Five patients treated with CMF and 3 patients not subjected to adjuvant chemotherapy, received human beta-interferon (IF, 2×106 IU/patient, i.m.), on days 0,7, and 15 for 6 cycles of 31 days each. The natural killer (NK) activity (NKA) of peripheral blood mononuclear cells (MNC) was tested 24 and 48 h after low-dose IF administration. The results of NKA determinations carried out for the 6 cycles of treatment show that (1) chemotherapy alone depressed NKA; (2) IF alone increased NKA in stage 1 patients not treated with CMF; (3) IF antagonized the depressive activity of CMF on NK function and significantly augumented NKA in the case of low "basal" cytotoxic activity detectable in MNC collected before IF administration. Parallel in vitro studies showed that the inhibitory effect on NKA provoked by CMF is due to cyclophosphamide present in the association and is effectively antagonized by IF. These data provide rational bases for using IF in immunochemotherapy regimens, when tumor cells are supposed to be susceptible to host control by the natural resistance function.

Original languageEnglish
Pages (from-to)86-91
Number of pages6
JournalCancer Immunology, Immunotherapy
Volume24
Issue number1
DOIs
Publication statusPublished - Feb 1987

Fingerprint

Interferon-beta
Natural Killer Cells
Cyclophosphamide
Methotrexate
Fluorouracil
Breast Neoplasms
Drug Therapy
Adjuvant Chemotherapy
Innate Immunity
Blood Cells
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy. / Tentori, Lucio; Fuggetta, Maria Pia; D'Atri, Stefania; Aquino, Angelo; Nunziata, Corrado; Roselli, Mario; Ballatore, Paolo; Bonmassar, Enzo; De Vecchis, Liana.

In: Cancer Immunology, Immunotherapy, Vol. 24, No. 1, 02.1987, p. 86-91.

Research output: Contribution to journalArticle

Tentori, L, Fuggetta, MP, D'Atri, S, Aquino, A, Nunziata, C, Roselli, M, Ballatore, P, Bonmassar, E & De Vecchis, L 1987, 'Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy', Cancer Immunology, Immunotherapy, vol. 24, no. 1, pp. 86-91. https://doi.org/10.1007/BF00199838
Tentori, Lucio ; Fuggetta, Maria Pia ; D'Atri, Stefania ; Aquino, Angelo ; Nunziata, Corrado ; Roselli, Mario ; Ballatore, Paolo ; Bonmassar, Enzo ; De Vecchis, Liana. / Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy. In: Cancer Immunology, Immunotherapy. 1987 ; Vol. 24, No. 1. pp. 86-91.
@article{8e1ec9c8e46847ea91aa2184ba0fc6f6,
title = "Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy",
abstract = "The present study was designed to test whether immunomodulating doses of human beta-interferon would affect the natural cell-mediated cytotoxic function in untreated breast cancer patients or in those subjected to antitumor therapy. Analyses were performed on 11 breast cancer patients, 3 at stage 1 and 8 at stage 2, the latter being subjected to cyclophosphamide, methotrexate, 5-Fluorouracil (CMF) adjuvant chemotherapy. Five patients treated with CMF and 3 patients not subjected to adjuvant chemotherapy, received human beta-interferon (IF, 2×106 IU/patient, i.m.), on days 0,7, and 15 for 6 cycles of 31 days each. The natural killer (NK) activity (NKA) of peripheral blood mononuclear cells (MNC) was tested 24 and 48 h after low-dose IF administration. The results of NKA determinations carried out for the 6 cycles of treatment show that (1) chemotherapy alone depressed NKA; (2) IF alone increased NKA in stage 1 patients not treated with CMF; (3) IF antagonized the depressive activity of CMF on NK function and significantly augumented NKA in the case of low {"}basal{"} cytotoxic activity detectable in MNC collected before IF administration. Parallel in vitro studies showed that the inhibitory effect on NKA provoked by CMF is due to cyclophosphamide present in the association and is effectively antagonized by IF. These data provide rational bases for using IF in immunochemotherapy regimens, when tumor cells are supposed to be susceptible to host control by the natural resistance function.",
author = "Lucio Tentori and Fuggetta, {Maria Pia} and Stefania D'Atri and Angelo Aquino and Corrado Nunziata and Mario Roselli and Paolo Ballatore and Enzo Bonmassar and {De Vecchis}, Liana",
year = "1987",
month = "2",
doi = "10.1007/BF00199838",
language = "English",
volume = "24",
pages = "86--91",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy

AU - Tentori, Lucio

AU - Fuggetta, Maria Pia

AU - D'Atri, Stefania

AU - Aquino, Angelo

AU - Nunziata, Corrado

AU - Roselli, Mario

AU - Ballatore, Paolo

AU - Bonmassar, Enzo

AU - De Vecchis, Liana

PY - 1987/2

Y1 - 1987/2

N2 - The present study was designed to test whether immunomodulating doses of human beta-interferon would affect the natural cell-mediated cytotoxic function in untreated breast cancer patients or in those subjected to antitumor therapy. Analyses were performed on 11 breast cancer patients, 3 at stage 1 and 8 at stage 2, the latter being subjected to cyclophosphamide, methotrexate, 5-Fluorouracil (CMF) adjuvant chemotherapy. Five patients treated with CMF and 3 patients not subjected to adjuvant chemotherapy, received human beta-interferon (IF, 2×106 IU/patient, i.m.), on days 0,7, and 15 for 6 cycles of 31 days each. The natural killer (NK) activity (NKA) of peripheral blood mononuclear cells (MNC) was tested 24 and 48 h after low-dose IF administration. The results of NKA determinations carried out for the 6 cycles of treatment show that (1) chemotherapy alone depressed NKA; (2) IF alone increased NKA in stage 1 patients not treated with CMF; (3) IF antagonized the depressive activity of CMF on NK function and significantly augumented NKA in the case of low "basal" cytotoxic activity detectable in MNC collected before IF administration. Parallel in vitro studies showed that the inhibitory effect on NKA provoked by CMF is due to cyclophosphamide present in the association and is effectively antagonized by IF. These data provide rational bases for using IF in immunochemotherapy regimens, when tumor cells are supposed to be susceptible to host control by the natural resistance function.

AB - The present study was designed to test whether immunomodulating doses of human beta-interferon would affect the natural cell-mediated cytotoxic function in untreated breast cancer patients or in those subjected to antitumor therapy. Analyses were performed on 11 breast cancer patients, 3 at stage 1 and 8 at stage 2, the latter being subjected to cyclophosphamide, methotrexate, 5-Fluorouracil (CMF) adjuvant chemotherapy. Five patients treated with CMF and 3 patients not subjected to adjuvant chemotherapy, received human beta-interferon (IF, 2×106 IU/patient, i.m.), on days 0,7, and 15 for 6 cycles of 31 days each. The natural killer (NK) activity (NKA) of peripheral blood mononuclear cells (MNC) was tested 24 and 48 h after low-dose IF administration. The results of NKA determinations carried out for the 6 cycles of treatment show that (1) chemotherapy alone depressed NKA; (2) IF alone increased NKA in stage 1 patients not treated with CMF; (3) IF antagonized the depressive activity of CMF on NK function and significantly augumented NKA in the case of low "basal" cytotoxic activity detectable in MNC collected before IF administration. Parallel in vitro studies showed that the inhibitory effect on NKA provoked by CMF is due to cyclophosphamide present in the association and is effectively antagonized by IF. These data provide rational bases for using IF in immunochemotherapy regimens, when tumor cells are supposed to be susceptible to host control by the natural resistance function.

UR - http://www.scopus.com/inward/record.url?scp=0023175955&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023175955&partnerID=8YFLogxK

U2 - 10.1007/BF00199838

DO - 10.1007/BF00199838

M3 - Article

VL - 24

SP - 86

EP - 91

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 1

ER -